Molecular microscope
Showing 1 - 25 of 5,263
Donor Derived Cell Free DNA and Histopathology in Kidney
Not yet recruiting
- Transplant;Failure,Kidney
- +2 more
- (no location specified)
Apr 11, 2023
Trifecta-Lung cfDNA-MMDx Study
Recruiting
- Lung Transplantation
-
Melbourne, Australia
- +5 more
Apr 18, 2023
Trifecta-Kidney cfDNA-MMDx Study
Recruiting
- Kidney Transplant Rejection
- MMDx
- +2 more
-
Tampa, Florida
- +30 more
Oct 12, 2022
Microarrays in Heart Transplantation
Recruiting
- Cardiac Transplant Disorder
- Endomyocardial biopsy
-
Los Angeles, California
- +10 more
Oct 27, 2021
Trifecta-Heart cfDNA-MMDx Study
Recruiting
- Heart Transplant Rejection
- MMDx diagnostic test
- +2 more
-
Los Angeles, California
- +9 more
Aug 2, 2022
Microarrays in Lung Transplantation
Recruiting
- Lung Transplant Rejection
- Lung transplant biopsy bites.
-
Baltimore, Maryland
- +9 more
Oct 17, 2022
Molecular Signature for Breast Cancer
Not yet recruiting
- Breast Cancer
- Diagnostic assistance tool
- (no location specified)
Feb 2, 2023
Molecular Mechanisms Underpinning Sarcopenic Obesity
Recruiting
- Sarcopenic Obesity
- +3 more
- Essential amino acids (EAA)
-
Stockholm, SwedenThe Swedish School of Sport and Health Sciences
Nov 1, 2023
Microarrays in Organ Transplantation
Recruiting
- Validation Study of Molecular Diagnostic System
- +2 more
-
Birmingham, Alabama
- +25 more
Aug 18, 2022
Microarrays in Liver Transplantation
Recruiting
- Liver Dysfunction
- liver biopsy
-
San Francisco, California
- +14 more
Mar 2, 2022
Vital Pulp Therapy Trial in Mansoura (Pulp therapy, Cytokines level in pulpal blood.)
Completed
- Vital Pulp Therapy
- Pulp therapy
- Cytokines level in pulpal blood.
-
Mansoura, Dakahliya, EgyptMansoura University
Jul 18, 2022
Lead Poisoning Trial in Karachi (Lead Acetate, Moringa oleifera Extract, Allium sativum Extract)
Active, not recruiting
- Lead Poisoning
- Lead Acetate
- +3 more
-
Karachi, Sindh, PakistanBaqai Medical University
Feb 15, 2023
Metastatic Melanoma Trial in Edmonton (Molecular Microscope Diagnostic system)
Unknown status
- Metastatic Melanoma
- Molecular Microscope Diagnostic system
-
Edmonton, Alberta, CanadaCross Cancer Institute
Dec 17, 2018
Type 1 Diabetes Trial in Edmonton (Implantation of Nylon catheter (Device-less sentinel unit))
Recruiting
- Type 1 Diabetes
- Implantation of Nylon catheter (Device-less sentinel unit)
-
Edmonton, Alberta, CanadaUniversity of Alberta Clinical Islet Transplant Program
May 10, 2022
Wilms Tumor, Renal Cancer Trial in Birmingham (Indocyanine Green (ICG))
Not yet recruiting
- Wilms Tumor
- Renal Cancer
- Indocyanine Green (ICG)
-
Birmingham, United KingdomBirmingham children's hospital
Feb 9, 2023
Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases
Recruiting
- Eosinophilic Myeloid Neoplasm
- Hypereosinophilic Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Vitiligo Trial in Sohag (Light microscopic studies, Immunohistochemical studies)
Not yet recruiting
- Vitiligo
- Light microscopic studies
- Immunohistochemical studies
-
Sohag, EgyptSohag University Hospital
May 19, 2023
Artificial Intelligence Neuropathologist
Recruiting
- CNS Tumor
- Neuropathology
-
Shanghai, Shanghai, ChinaHushan Hospital, Fudan University
Mar 20, 2022
Pathology of Helicases and Premature Aging: Study by Derivation
Terminated
- Age Problem
- taking of cutaneous cells
-
Montpellier, FranceUniversity Hospital Montpellier
Dec 8, 2021
Glioma Trial in London (Advanced MRI sequences)
Not yet recruiting
- Glioma
- Advanced MRI sequences
-
London, United KingdomKing's R&I department
Feb 22, 2022
Neurologic Findings Trial in Taipei City (Methylene blue intradermal injection)
Recruiting
- Neurologic Findings
- Methylene blue intradermal injection
-
Taipei City, TaiwanNational Taiwan University Hosipital
Sep 19, 2022
Kidney Transplantation Trial in Germany (MIC, Standard of Care)
Recruiting
- Kidney Transplantation
- MIC
- Standard of Care
-
Frankfurt, Germany
- +4 more
Oct 11, 2022
Differential Leucocyte Count and Covid-19 Diagnosis
Withdrawn
- SARS-CoV-2 Infection Covid19
- Differential Leucocyte Count (CLDC) device and algorithm
-
Pozzilli, IS, ItalyIRCCS INM Neuromed, Department of Epidemiology and Prevention
Jan 11, 2022
Pituitary Tumor, Pituitary Adenoma, Pituitary Macroadenoma Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence
Recruiting
- Pituitary Tumor
- +2 more
- Bevacizumab-IRDye800CW
- Molecular Fluorescence Endoscopy platform
-
Groningen, NetherlandsUniversity Medical Center Groningen
Aug 31, 2021